Sciact
  • EN
  • RU

Identification of a novel 1,2 oxazine that can induce apoptosis by targeting NF-κB in hepatocellular carcinoma cells Научная публикация

Журнал Biotechnology Reports
ISSN: 2215-017X
Вых. Данные Год: 2020, Том: 25, Номер статьи : e00438, Страниц : DOI: 10.1016/j.btre.2020.e00438
Авторы Somu Chaithanya 1 , Mohan Chakrabhavi Dhananjaya 2 , Ambekar Sachin 3 , Dukanya _ 4 , Rangappa Shobith 5 , Baburajeev CP 3 , Sukhorukov Alexey 6 , Mishra Srishti 7 , Shanmugam Muthu K 7 , Chinnathambi Arunachalam 8 , Awad Alahmadi Tahani 9 , Alharbi Sulaiman Ali 8 , Basappa _ 3,4 , Rangappa Kanchugarakoppal S. 1
Организации
1 Department of Studies in Chemistry, University of Mysore, Manasagangotri, Mysore 570006, India
2 Department of Studies in Molecular Biology, University of Mysore, Manasagangotri, Mysore 570006, India
3 Laboratory of Chemical Biology, Department of Chemistry, Bangalore University, Central College Campus, Palace Road, Bangalore 560001, India
4 Laboratory of Chemical Biology, Department of Studies in Organic Chemistry, University of Mysore, Manasagangotri, Mysore 570006, India
5 Adichunchanagiri Institute for Molecular Medicine, BG Nagara, Nagamangala Taluk, Mandya district-571448, India
6 N.D. Zelinsky Institute of Organic Chemistry, Leninsky Prospect, Moscow 119991, Russia
7 Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore 117600, Singapore
8 Department of Botany and Microbiology, College of Science, King Saud University, Riyadh -11451, Saudi Arabia
9 Department of Pediatrics, College of Medicine and King Khalid University Hospital, King Saud University Medical City, Riyadh 11461, Saudi Arabia

Реферат: Constitutive activation of NF-κB is associated with proinflammatory diseases and suppression of the NF-κB signaling pathway has been considered as an effective therapeutic strategy in the treatment of various cancers including hepatocellular carcinoma (HCC). Herein, we report the synthesis of 1,2 oxazines and their anticancer potential. The antiproliferative studies presented 3-((4-(1H-benzo[d]imidazol-2-yl)piperidin-1-yl)methyl)-4-phenyl-4,4a,5,6,7,7a-hexahydrocyclopenta [e][1,2]oxazine(3i) as a lead cytotoxic agent against HCC cells. Flow cytometric analysis showed that 3i caused a substantial increase in the subG1 cell population. Annexin-V-FITC-PI staining showed a significant increase in the percentage of apoptotic cells on treatment with 3i. Transfection with p65 siRNA significantly reduced the 3i induced DNA fragmentation indicating that 3i may primarily mediate its proapoptotic effects by abrogating the NF-κB signaling. In addition, treatment of HCC cells with 3i decreased the DNA binding ability of NF-κB and NF-κB-dependent luciferase expression. Taken together, this report introduces 1,2-oxazine that potently targets the NF-κB signaling pathway in HCC cells.
Библиографическая ссылка: Somu C. , Mohan C.D. , Ambekar S. , Dukanya _. , Rangappa S. , Baburajeev C. , Sukhorukov A. , Mishra S. , Shanmugam M.K. , Chinnathambi A. , Awad Alahmadi T. , Alharbi S.A. , Basappa _. , Rangappa K.S.
Identification of a novel 1,2 oxazine that can induce apoptosis by targeting NF-κB in hepatocellular carcinoma cells
Biotechnology Reports. 2020. V.25. e00438 . DOI: 10.1016/j.btre.2020.e00438 Scopus OpenAlex
Идентификаторы БД:
Scopus: 2-s2.0-85080027972
OpenAlex: W3008274095
Цитирование в БД:
БД Цитирований
OpenAlex 17
Scopus 17
Альметрики: